Epitope Claims Live On at the European Patent Office | Jones Day
While the genus antibody declare was successfully killed by the U.S. Supreme Court in Amgen v. Sanofi, it lives on in Europe regardless of a couple of current setbacks at the European Patent Office (“EPO”) and the Unified Patent Court (“UPC”). Following the (in)well-known Amgen v. Sanofi choice, which has declared invalid generic antibody claiming […]
Epitope Claims Live On at the European Patent Office | Jones Day Read More »